|Articles|May 11, 2015
Myoderm Joins SCRS as Global Impact Partner
The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization.
Advertisement
The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization. Myoderm will participate as a Global Impact Partner (GIP) and align with sponsors, CROs and other industry solution providers who share an ongoing commitment to promoting site sustainability across the clinical trials landscape.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement